Latest Articles

Publication Date
Reproductive Autonomy and Insurer Denials of Care: The Fine Line Between Oversight and Interference.

AbstractReproductive autonomy is a fundamental ethical principle in healthcare, yet insurance denials of care often undermine patient decision-making. This article examines a case in which a 35-year-old patient with stage …

Published: Aug. 27, 2025, midnight
Nanotechnology strategies for endometrium health: Are we on the right track?

The endometrium is a vital mucosal tissue which undergoes cyclical regeneration, differentiation, and remodeling upon hormonal, cellular, and molecular signaling networks. Dysregulation of these processes can trigger a range of …

Published: Aug. 27, 2025, midnight
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review.

Background/Objectives: Rarely, primary (PriCs) or metastatic (metECs) carcinomas occur in the episiotomy site. Methods: A systematic literature review of metECs was carried out. We reviewed the PRISMA guidelines and the …

Published: Aug. 27, 2025, midnight
New Perspectives on the Use of Resveratrol in the Treatment of Metabolic and Estrogen-Dependent Conditions Through Hormonal Modulation and Anti-Inflammatory Effects.

Estrogen-dependent conditions, such as endometriosis, adenomyosis, lipedema, polycystic ovary syndrome, and breast cancer, are intimately involved with hormonal changes related to estrogen and their receptors. These conditions can be expressed …

Published: Aug. 27, 2025, midnight
Does MDWD show high probability of rebound - Quarterly Growth Report & Accurate Intraday Trading Signals - Newser

Does MDWD show high probability of rebound - Quarterly Growth Report & Accurate Intraday Trading Signals Newser

Published: Aug. 26, 2025, 10:09 p.m.
Analyzing ImmunityBio Inc. with multi timeframe charts - July 2025 Institutional & Risk Controlled Daily Plans - Newser

Analyzing ImmunityBio Inc. with multi timeframe charts - July 2025 Institutional & Risk Controlled Daily Plans Newser

Published: Aug. 26, 2025, 4:22 p.m.
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced - PharmiWeb.com

Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced PharmiWeb.com

Published: Aug. 26, 2025, 4:10 p.m.
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC) - Yahoo Finance

Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC) Yahoo Finance

Published: Aug. 26, 2025, noon
What Fibonacci levels say about DBRG.PRH rebound - Dividend Hike & Daily Chart Pattern Signal Reports - Newser

What Fibonacci levels say about DBRG.PRH rebound - Dividend Hike & Daily Chart Pattern Signal Reports Newser

Published: Aug. 26, 2025, 8:32 a.m.
Six to seven times less likely to be physically active: Low self-determination and basic psychological needs support in women with endometriosis-A cluster analysis.

To explore how clusters of motivational regulations, self-determination, and basic psychological needs (BPNs) relate to physical exercise participation in women with endometriosis.

Published: Aug. 26, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!